{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:53:43Z","timestamp":1792000423639,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["K08DK092287"],"award-info":[{"award-number":["K08DK092287"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1053\/j.ajkd.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T03:46:12Z","timestamp":1365219972000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":266,"title":["Lifetime Incidence of CKD Stages 3-5 in the United States"],"prefix":"10.1053","volume":"62","author":[{"given":"Morgan E.","family":"Grams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric K.H.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1053\/j.ajkd.2013.03.009_bib1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2013.03.009_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5301\/jn.5000197","article-title":"Long-term risk projection and its application to nephrology research","volume":"25","author":"Turin","year":"2012","journal-title":"J Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2013.03.009_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.1053\/j.ajkd.2013.03.009_bib4","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"issue":"17","key":"10.1053\/j.ajkd.2013.03.009_bib5","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"24","key":"10.1053\/j.ajkd.2013.03.009_bib6","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer","year":"2011","journal-title":"JAMA"},{"issue":"9731","key":"10.1053\/j.ajkd.2013.03.009_bib7","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.009_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.009_bib9","first-page":"e1","article-title":"United States Renal Data System 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2013.03.009_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.ajkd.2010.08.016","article-title":"Association of CKD with disability in the United States","volume":"57","author":"Plantinga","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"9758","key":"10.1053\/j.ajkd.2013.03.009_bib11","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0140-6736(10)61271-8","article-title":"Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study","volume":"376","author":"James","year":"2010","journal-title":"Lancet"},{"issue":"9854","key":"10.1053\/j.ajkd.2013.03.009_bib12","first-page":"1662","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.ajkd.2013.03.009_bib13","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/01.ASN.0000070156.78824.C7","article-title":"National kidney disease education program","volume":"14","author":"Hostetter","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.009_bib14","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1053\/j.ajkd.2008.05.038","article-title":"The National Kidney Disease Education Program: improving understanding, detection, and management of CKD","volume":"53","author":"Narva","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1053\/j.ajkd.2013.03.009_bib15","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/archinte.168.20.2268","article-title":"Patient awareness of chronic kidney disease: trends and predictors","volume":"168","author":"Plantinga","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2013.03.009_bib16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/01.ASN.0000014251.87778.01","article-title":"Cumulative risk for developing end-stage renal disease in the US population","volume":"13","author":"Kiberd","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.03.009_bib17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1681\/ASN.2012020164","article-title":"Lifetime risk of ESRD","volume":"23","author":"Turin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2013.03.009_bib18","doi-asserted-by":"crossref","first-page":"c5869","DOI":"10.1136\/bmj.c5869","article-title":"Population based screening for chronic kidney disease: cost effectiveness study","volume":"341","author":"Manns","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.009_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/j.ajkd.2009.11.016","article-title":"A health policy model of CKD: 1","volume":"55","author":"Hoerger","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.009_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ajkd.2009.09.006","article-title":"Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"55","author":"Bash","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2013.03.009_bib21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.009_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2215\/CJN.06450611","article-title":"Racial differences in the incidence of chronic kidney disease","volume":"7","author":"Muntner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.009_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ndt\/gfq473","article-title":"Race differences in access to health care and disparities in incident chronic kidney disease in the US","volume":"26","author":"Evans","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2013.03.009_bib24","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/01.ASN.0000026493.18542.6A","article-title":"Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors","volume":"13","author":"Tarver-Carr","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.03.009_bib25","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2010101085","article-title":"Albuminuria and racial disparities in the risk for ESRD","volume":"22","author":"McClellan","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2013.03.009_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1681\/ASN.2010090960","article-title":"Racial and ethnic differences in kidney function decline among persons without chronic kidney disease","volume":"22","author":"Peralta","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2013.03.009_bib27","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/ndt\/gfs052","article-title":"Chronic kidney disease and life expectancy","volume":"27","author":"Turin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2013.03.009_bib28","first-page":"1","article-title":"United States life tables, 2007","volume":"59","author":"Arias","year":"2011","journal-title":"Natl Vital Stat Rep"},{"issue":"22","key":"10.1053\/j.ajkd.2013.03.009_bib29","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2013.03.009_bib30","series-title":"Epidemiology: Beyond the Basics","author":"Szklo","year":"2007"},{"issue":"9147","key":"10.1053\/j.ajkd.2013.03.009_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","article-title":"Lifetime risk of developing coronary heart disease","volume":"353","author":"Lloyd-Jones","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.ajkd.2013.03.009_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/aje\/kwp151","article-title":"Defining incident chronic kidney disease in the research setting: the ARIC Study","volume":"170","author":"Bash","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1053\/j.ajkd.2013.03.009_bib35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease","volume":"42","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.009_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000212381","article-title":"Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C","volume":"30","author":"Shlipak","year":"2009","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.009_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2215\/CJN.08070811","article-title":"Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women","volume":"7","author":"Semba","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2013.03.009_bib38","doi-asserted-by":"crossref","first-page":"c2","DOI":"10.1159\/000328013","article-title":"Classification of chronic kidney disease in the elderly: pitfalls and errors","volume":"119","author":"Winearls","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"23","key":"10.1053\/j.ajkd.2013.03.009_bib39","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.6455","article-title":"Rates of treated and untreated kidney failure in older vs younger adults","volume":"307","author":"Hemmelgarn","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2013.03.009_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11606-010-1511-x","article-title":"Chronic kidney disease and the risk of end-stage renal disease versus death","volume":"26","author":"Dalrymple","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1053\/j.ajkd.2013.03.009_bib41","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ki.2008.701","article-title":"Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans","volume":"75","author":"Freedman","year":"2009","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2013.03.009_bib42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"issue":"9","key":"10.1053\/j.ajkd.2013.03.009_bib43","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI46263","article-title":"Genetics of kidney failure and the evolving story of APOL1","volume":"121","author":"Friedman","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2013.03.009_bib44","series-title":"USRDS 2000 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2000"},{"issue":"10","key":"10.1053\/j.ajkd.2013.03.009_bib45","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1681\/ASN.2005101122","article-title":"Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease","volume":"17","author":"Peralta","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613006641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613006641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:07:59Z","timestamp":1759457279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638613006641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0272638613006641"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.009","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime Incidence of CKD Stages 3-5 in the United States","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}